Ovid Therapeutics Inc. (OVID)

NCM – Real Time Price. Currency in USD

2.53

-0.05 (-1.94%)

Market open: Aug 12, 2026, 10:05 AM EDT

2.62

+0.04 (1.55%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

566K

392K

Cost of goods sold

-300K

-600K

-2M

-1M

Gross Profit

-34K

-1M

121K

Operating expenses (excl. COGS)

-49M

-62M

-58M

-56M

Operating Income

-42M

-62M

-59M

-56M

Non-operating income, total

25M

35M

Pretax income

-17M

-26M

-52M

-54M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-17M

-26M

-52M

-54M

Discontinued operations

Net income

-17M

-26M

-52M

-54M

Dilution adjustment

Preferred dividends

Ovid Therapeutics Inc. (OVID)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ovid Therapeutics Inc. (OVID)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Ovid Therapeutics Inc. (OVID)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ovid Therapeutics Inc. (OVID)

Income Statement (Annual)

Income Statement (Annual)